#Avantect
LightNews LightNews
southamptonctu.bsky.social
#EarlyDiagnosis of #PancreaticCancer could help save more lives.

The SAFE-D study is recruiting people with newly diagnosed type 2 #diabetes, a known risk factor for the disease - bit.ly/44bgkoS

#PancreaticCancerAwarenessMonth #PurpleForPancreaticCancer #MostProudOf
A graphic with a white a purple background. On the left is a round photo of Sam Wilding, Senior Statistician for the SAFE-D trial, with a purple surround, and on the right is the quote "There are few blood tests for pancreatic cancer available that have rigorous scientific evidence. The data behind the Avantect Pancreatic Cancer Test is very promising, and if the SAFE-D study shows that it works well in a real-world scenario then this can transform the outlook for pancreatic cancer. I'm most proud of being part of the SAFE-D team and our aim to revolutionise the pancreatic cancer diagnosis journey." Underneath the quote are the social media hashtags #PurpleForPancreaticCancer, #PancreaticCancerAwarenessMonth, and #MostProudOf in purple writing. On the bottom left are the Southampton Clinical Trials Unit, University Hospital Southampton, University of Southampton, and Clearnote Health logos.
November 26, 2025 at 8:29 AM
clearnotehealth.bsky.social
We were delighted to attend the premiere of Modì, directed by Johnny Depp and starring Al Pacino. Our team was out in force spreading awareness about the importance of early cancer detection.

Learn more about the Avantect test: www.avantect.com
November 5, 2025 at 5:10 PM
onclive.bsky.social
Avantect Multi-Cancer and Ovarian Cancer Detection Tests Achieve UKCA Marking
#OvarianCancer #Oncology #gyncsm
www.onclive.com/view/avantec...
Avantect Multi-Cancer and Ovarian Cancer Detection Tests Achieve UKCA Marking | OncLive
A United Kingdom Conformity Assessed marking was granted to the Avantect Multi-Cancer Detection Test and Avantect Ovarian Cancer Test.
www.onclive.com
September 25, 2025 at 3:13 PM
uk-nb.bsky.social
ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test

https://www.newsbeep.com/uk/159396/

SAN DIEGO–(BUSINESS WIRE)–#5hmC—ClearNote Health, a company focused on improving early detection for some of …
ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test - United Kingdom News Beep
SAN DIEGO--(BUSINESS WIRE)--#5hmC--ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced that it
www.newsbeep.com
September 25, 2025 at 11:30 AM
clearnotehealth.bsky.social
📢 Press Release: ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test

www.clearnotehealth.com/press-releas...
September 25, 2025 at 10:20 AM
newsen.bsky.social
Human Longevity, Inc. Enhances $1 Million Initiative for Late-Stage Ovarian Cancer Prevention#USA#South_San_Francisco#Human_Longevity#Ovarian_Cancer#Avantect
Human Longevity, Inc. Enhances $1 Million Initiative for Late-Stage Ovarian Cancer Prevention
Human Longevity, Inc. expands its $1 million cancer prevention initiative to include late-stage ovarian cancer, promoting early detection and treatment.
third-news.com
July 17, 2025 at 10:48 PM
lgoodbu.bsky.social
ClearNote Health Receives First In Vitro Diagnostic Approval for its Avantect® Pancreatic ... - goo.gl/alerts/2Z8jBh #GoogleAlerts
ClearNote Health Receives First In Vitro Diagnostic Approval for its Avantect® Pancreatic Cancer Test
SAN DIEGO, July 09, 2025--ClearNote Health has received UK Conformity Assessed marking for its Avantect® Pancreatic Cancer Test.
goo.gl
July 9, 2025 at 11:13 PM
lgoodbu.bsky.social
ClearNote Health Receives First In Vitro Diagnostic Approval for its Avantect® Pancreatic ... - goo.gl/alerts/CrAro4 #GoogleAlerts
ClearNote Health Receives First In Vitro Diagnostic Approval for its Avantect® Pancreatic Cancer Test
SAN DIEGO, July 09, 2025--ClearNote Health has received UK Conformity Assessed marking for its Avantect® Pancreatic Cancer Test.
goo.gl
July 9, 2025 at 9:34 PM
clearnotehealth.bsky.social
📢 We are happy to announce that ClearNote Health has received UK Conformity Assessed (UKCA) marking for its Avantect® Pancreatic Cancer Test.

www.clearnotehealth.com/press-releas...
July 9, 2025 at 12:28 PM
lgoodbu.bsky.social
ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase ... - BioSpac - goo.gl/alerts/XCdUA6 #GoogleAlerts
ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients
goo.gl
June 18, 2025 at 2:23 PM
lgoodbu.bsky.social
ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase ... - BioSpac - goo.gl/alerts/uHi8K1 #GoogleAlerts
ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients
goo.gl
June 16, 2025 at 9:53 PM
clearnotehealth.bsky.social
📢 Press Release: ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients

With up to 15,000 patient participants, it will be the largest study of its kind!

www.clearnotehealth.com/press-releas...

#pancreaticcancer
June 16, 2025 at 12:04 PM
clearnotehealth.bsky.social
📢 Press Release: Human Longevity, Inc., Expands Cancer Prevention Offering by Selecting the ClearNote Health Avantect® Early Detection #PancreaticCancer Test.

www.prnewswire.com/news-release...
May 6, 2025 at 12:16 PM
newsen.bsky.social
Human Longevity, Inc. Enhances Cancer Prevention with Avantect Test for Early Detection of Pancreatic Cancer#USA#pancreatic_cancer#South_San_Francisco#Human_Longevity#Avantect
Human Longevity, Inc. Enhances Cancer Prevention with Avantect Test for Early Detection of Pancreatic Cancer
Human Longevity, Inc. announces a significant expansion in cancer prevention with the integration of the Avantect test, enhancing early pancreatic cancer detection.
third-news.com
May 6, 2025 at 11:21 AM
clearnotehealth.bsky.social
Join ClearNote Health at Digestive Disease Week (#DDW) in San Diego May 406, where we’ll be showcasing the #Avantect Pancreatic Cancer Test - a groundbreaking epigenomic liquid biopsy designed to aid in the early detection of pancreatic cancer.

Visit us at booth 5525
April 29, 2025 at 6:26 PM
lgoodbu.bsky.social
ClearNote Health's Avantect® Pancreatic Cancer Test Now Available to Health Plan ... - Silicon - goo.gl/alerts/SweGXc #GoogleAlerts
ClearNote Health’s Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev’s National PPO Networks - Silicon UK
ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced an agreement with Claritev, Inc. (“Claritev”) (NYSE: CTEV), previously MultiPlan, In...
goo.gl
March 13, 2025 at 8:39 AM
lgoodbu.bsky.social
ClearNote Health's Avantect® Pancreatic Cancer Test Now Available to Health Plan ... - BioSpace - goo.gl/alerts/NCH6ZX #GoogleAlerts
ClearNote Health’s Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev’s National PPO Networks
goo.gl
March 12, 2025 at 10:16 PM
stocktitan.net
#CTEV #MPLN ClearNote Health’s Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev’s National PPO Networks

https://www.stocktitan.net/news/CTEV/clear-note-health-s-avantect-pancreatic-cancer-test-now-available-to-al2p3r8z2u38.html
Revolutionary Pancreatic Cancer Detection Test Now Available Nationwide: What Makes Avantect a Game-Changer
Innovative DNA-based blood screening for early pancreatic cancer detection now available through PHCS and MultiPlan networks, targeting high-risk patients with advanced AI technology.
www.stocktitan.net
March 12, 2025 at 12:03 PM
lgoodbu.bsky.social
ClearNote Health Earns Approval for Avantect® Pancreatic Cancer Test from New York ... - goo.gl/alerts/97h8rZ #GoogleAlerts
ClearNote Health Earns Approval for Avantect® Pancreatic Cancer Test from New York State Department of Health
goo.gl
February 18, 2025 at 9:11 PM
lgoodbu.bsky.social
ClearNote Health’s Avantect® Test Selected for World’s Largest Study of Pancreatic Cancer Detection in High-Risk Patient Population - www.businesswire.com/news/home/20...
ClearNote Health’s Avantect® Test Selected for World’s Largest Study of Pancreatic Cancer Detection in High-Risk Patient Population
ClearNote Health's Avantect® Pancreatic Cancer Test will be used in a landmark study of pancreatic cancer detection in high-risk patient population
www.businesswire.com
December 20, 2024 at 6:39 PM